These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2095944)

  • 1. Responses of growth hormone to desipramine in endogenous and non-endogenous depression.
    Dinan TG; Barry S
    Br J Psychiatry; 1990 May; 156():680-4. PubMed ID: 2095944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine challenge tests in depression: a study of growth hormone, TRH and cortisol release.
    Barry S; Dinan TG
    J Affect Disord; 1990 Apr; 18(4):229-34. PubMed ID: 2140374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine aspects of primary endogenous depression. X: Serum growth hormone measures in patients and matched control subjects.
    Rubin RT; Poland RE; Lesser IM
    Biol Psychiatry; 1990 May; 27(10):1065-82. PubMed ID: 2111183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone release after desipramine in depressive illness.
    Meesters P; Kerkhofs M; Charles G; Decoster C; Vanderelst M; Mendlewicz J
    Eur Arch Psychiatry Neurol Sci; 1985; 235(3):140-2. PubMed ID: 4092710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine challenge studies in puerperal psychoses. Dexamethasone suppression and TRH stimulation.
    Paykel ES; del Campo AM; White W; Horton R
    Br J Psychiatry; 1991 Aug; 159():262-6. PubMed ID: 1773243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interepisode consistency of dexamethasone suppression test results in affective disorders.
    Brizer DA; Brown RP; Kocsis JH; Stokes PE
    Am J Psychiatry; 1986 Apr; 143(4):539-41. PubMed ID: 3953899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal differences between psychotic and non-psychotic melancholic depression.
    Contreras F; Menchon JM; Urretavizcaya M; Navarro MA; Vallejo J; Parker G
    J Affect Disord; 2007 Jun; 100(1-3):65-73. PubMed ID: 17098292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Course of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985.
    Angst J; Preisig M
    Schweiz Arch Neurol Psychiatr (1985); 1995; 146(1):5-16. PubMed ID: 7792568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of biologic markers in a general hospital affective disorders program.
    Lieber AL; Newbury N
    J Clin Psychiatry; 1985 Jun; 46(6):217-21. PubMed ID: 3922959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dexamethasone suppression test in psychotic disorders.
    Arana GW; Barreira PJ; Cohen BM; Lipinski JF; Fogelson D
    Am J Psychiatry; 1983 Nov; 140(11):1521-3. PubMed ID: 6625007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of clonidine on growth hormone release in psychiatric patients and controls.
    Matussek N; Ackenheil M; Hippius H; Müller F; Schröder HT; Schultes H; Wasilewski B
    Psychiatry Res; 1980 Mar; 2(1):25-36. PubMed ID: 6251501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the ICD-10 diagnostic subtype of depression in bipolar disorder compared to recurrent depressive disorder.
    Kessing LV; Jensen HM; Christensen EM
    Psychopathology; 2008; 41(3):141-6. PubMed ID: 18187963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cycloid psychotic disorder: validation of the concept by means of a follow-up and a family study.
    Maj M
    Psychopathology; 1990; 23(4-6):196-204. PubMed ID: 2084770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shortened REM latency as a psychobiological marker for psychotic depression? An age-, gender-, and polarity-controlled study.
    Stefos G; Staner L; Kerkhofs M; Hubain P; Mendlewicz J; Linkowski P
    Biol Psychiatry; 1998 Dec; 44(12):1314-20. PubMed ID: 9861474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological markers for endogenous depression in series and parallel.
    Feinberg M; Carroll BJ
    Biol Psychiatry; 1984 Jan; 19(1):3-11. PubMed ID: 6704459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term course of seasonal affective disorders: a preliminary report.
    Sakamoto K; Nakadaira S; Kamo K; Tomitaka S; Kamo T
    Jpn J Psychiatry Neurol; 1993 Jun; 47(2):470-2. PubMed ID: 8271641
    [No Abstract]   [Full Text] [Related]  

  • 17. Testing the comparability of psychiatric diagnoses in ICD-10 and DSM-III-R.
    Hiller W; Dichtl G; Hecht H; Hundt W; von Zerssen D
    Psychopathology; 1994; 27(1-2):19-28. PubMed ID: 7972636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive neuropsychiatry and the future of diagnosis: a 'PC' model of the mind.
    Charlton BG
    Br J Psychiatry; 1995 Aug; 167(2):149-53; discussion 153-8. PubMed ID: 7582663
    [No Abstract]   [Full Text] [Related]  

  • 19. Factor analysis of the Montgomery-Asberg Depression Rating Scale.
    Craighead WE; Evans DD
    Depression; 1996; 4(1):31-3. PubMed ID: 9160651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone responses to the alpha 2-adrenoceptor agonist guanfacine and to growth hormone releasing hormone in depressed patients and controls.
    Eriksson E; Balldin J; Lindstedt G; Modigh K
    Psychiatry Res; 1988 Oct; 26(1):59-67. PubMed ID: 2907163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.